Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
- Örn Almarsson
- , Michael J. Zaworotko
- TransForm Pharmaceutical, Inc.
- Merck, Inc.
- University of South Florida
Research output: Contribution to journal › Review article › peer-review